Connect Biopharmaceuticals is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. We leverage our expertise in the biology of T cell modulation to build a strong portfolio of innovative product candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Our aim is to improve the lives of patients in China and around the world by creating novel medicines with better efficacy and fewer side effects.


TEL/FAX: 0512-53577866

E-MAIL: swlu@connectpharm.com

ADD: Science and Technology Park, East R&D Building , 3rd Floor , 6 Beijing West Road, Taicang, Jiangsu, China 215400

Copyright: Suzhou Connect Biopharmaceuticals, Ltd. 苏ICP备17002143号

Technical support: Epower